drugset / Trial / NCT02017639
Sarilumab Effect on the Pharmacokinetics of Simvastatin
Non-randomizedSingle-groupOpen-labelHealth-services research
Summary
Primary Objective: To evaluate the effect of a single 200 mg subcutaneous injection of sarilumab on the pharmacokinetics of simvastatin in patients with rheumatoid arthritis Secondary Objective: To describe the safety and efficacy (exploratory) of sarilumab
Timeline
- Start
- 2014-01
- Primary completion
- 2016-03
- Completion
- 2016-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sarilumab | Monoclonal antibody | 200 mg | Subcutaneous |
| Subject | Simvastatin | Small molecule | 40 mg | Oral |